Literature DB >> 33482830

Sex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis.

Arnaud Bisson1, Alexandre Bodin1, Grégoire Fauchier2, Julien Herbert1,3, Denis Angoulvant1,4, Pierre Henri Ducluzeau2,5, Gregory Y H Lip6,7, Laurent Fauchier8.   

Abstract

BACKGROUND: There remain uncertainties regarding diabetes mellitus and the incidence of atrial fibrillation (AF), in relation to type of diabetes, and the interactions with sex and age. We investigated whether diabetes confers higher relative rates of AF in women compared to men, and whether these sex-differences depend on type of diabetes and age.
METHODS: All patients aged ≥ 18 seen in French hospitals in 2013 with at least 5 years of follow-up without a history of AF were identified and categorized by their diabetes status. We calculated overall and age-dependent incidence rates, hazard ratios, and women-to-men ratios for incidence of AF in patients with type 1 and type 2 diabetes (compared to no diabetes).
RESULTS: In 2,921,407 patients with no history of AF (55% women), 45,389 had prevalent type 1 diabetes and 345,499 had prevalent type 2 diabetes. The incidence rates (IRs) of AF were higher in type 1 or type 2 diabetic patients than in non-diabetics, and increased with advancing age. Among individuals with diabetes, the absolute rate of AF was higher in men than in women. When comparing individuals with and without diabetes, women had a higher adjusted hazard ratio (HR) of AF than men: adjusted HR 1.32 (95% confidence interval 1.27-1.37) in women vs. 1.12(1.08-1.16) in men for type 1 diabetes, adjusted HR 1.17(1.16-1.19) in women vs. 1.10(1.09-1.12) in men for type 2 diabetes.
CONCLUSION: Although men have higher absolute rates for incidence of AF, the relative rates of incident AF associated with diabetes are higher in women than in men for both type 1 and type 2 diabetes.

Entities:  

Keywords:  Atrial fibrillation; Diabetes; Sex-difference

Year:  2021        PMID: 33482830      PMCID: PMC7821402          DOI: 10.1186/s12933-021-01216-7

Source DB:  PubMed          Journal:  Cardiovasc Diabetol        ISSN: 1475-2840            Impact factor:   9.951


  38 in total

1.  Hospital discharge data can be used for monitoring procedures and intensive care related to severe maternal morbidity.

Authors:  Anne A Chantry; Catherine Deneux-Tharaux; Christine Cans; Anne Ego; Catherine Quantin; Marie-Hélène Bouvier-Colle
Journal:  J Clin Epidemiol       Date:  2011-02-18       Impact factor: 6.437

Review 2.  Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation.

Authors:  Rachel R Huxley; Kristian B Filion; Suma Konety; Alvaro Alonso
Journal:  Am J Cardiol       Date:  2011-04-27       Impact factor: 2.778

3.  Effects of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes in women versus men.

Authors:  Karin Rådholm; Zien Zhou; Kristin Clemens; Bruce Neal; Mark Woodward
Journal:  Diabetes Obes Metab       Date:  2019-09-30       Impact factor: 6.577

4.  Type II diabetes abrogates sex differences in endothelial function in premenopausal women.

Authors:  H O Steinberg; G Paradisi; J Cronin; K Crowde; A Hempfling; G Hook; A D Baron
Journal:  Circulation       Date:  2000-05-02       Impact factor: 29.690

5.  Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study.

Authors:  Laurent Fauchier; Nicolas Clementy; Christele Pelade; Cecile Collignon; Emmanuelle Nicolle; Gregory Y H Lip
Journal:  Stroke       Date:  2015-08-06       Impact factor: 7.914

6.  Loss of insulin signaling may contribute to atrial fibrillation and atrial electrical remodeling in type 1 diabetes.

Authors:  Iuliia Polina; Hailey J Jansen; Tiesong Li; Motahareh Moghtadaei; Loryn J Bohne; Yingjie Liu; Pooja Krishnaswamy; Emmanuel E Egom; Darrell D Belke; Sara A Rafferty; Martin Ezeani; Anne M Gillis; Robert A Rose
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-20       Impact factor: 11.205

Review 7.  Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus.

Authors:  Alexandra Kautzky-Willer; Jürgen Harreiter; Giovanni Pacini
Journal:  Endocr Rev       Date:  2016-05-09       Impact factor: 19.871

8.  Association between elevated blood glucose level and non-valvular atrial fibrillation: a report from the Guangzhou heart study.

Authors:  Lu Fu; Hai Deng; Wei-Dong Lin; Shang-Fei He; Fang-Zhou Liu; Yang Liu; Xian-Zhang Zhan; Xian-Hong Fang; Hong-Tao Liao; Wei Wei; Zi-Li Liao; Li-Hong Tang; Zu-Yi Fu; Mu-Rui Zheng; Shu-Lin Wu; Yu-Mei Xue
Journal:  BMC Cardiovasc Disord       Date:  2019-11-28       Impact factor: 2.298

9.  Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes.

Authors:  Ioanna Gouni-Berthold; Heiner K Berthold; Christos S Mantzoros; Michael Böhm; Wilhelm Krone
Journal:  Diabetes Care       Date:  2008-03-28       Impact factor: 19.112

10.  Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men?

Authors:  Morten Malmborg; Michelle D S Schmiegelow; Caroline H Nørgaard; Anders Munch; Thomas Gerds; Morten Schou; Caroline Kistorp; Christian Torp-Pedersen; Mark A Hlatky; Gunnar Gislason
Journal:  Eur Heart J       Date:  2020-04-01       Impact factor: 29.983

View more
  3 in total

1.  Glucose-lowering drug use and new-onset atrial fibrillation in patients with diabetes mellitus.

Authors:  Gregoire Fauchier; Arnaud Bisson; Alexandre Bodin; Julien Herbert; Denis Angoulvant; Pierre Henri Ducluzeau; Gregory Y H Lip; Laurent Fauchier
Journal:  Diabetologia       Date:  2021-08-25       Impact factor: 10.122

2.  Sodium-Glucose Co-Transporter Inhibitors and Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Arjun K Pandey; Iva Okaj; Hargun Kaur; Emilie P Belley-Cote; Jia Wang; Alireza Oraii; Alexander P Benz; Linda S B Johnson; Jack Young; Jorge A Wong; Subodh Verma; David Conen; Hertzel Gerstein; Jeff S Healey; William F McIntyre
Journal:  J Am Heart Assoc       Date:  2021-08-28       Impact factor: 5.501

Review 3.  Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation.

Authors:  Andreas S Papazoglou; Anastasios Kartas; Dimitrios V Moysidis; Christos Tsagkaris; Stavros P Papadakos; Alexandra Bekiaridou; Athanasios Samaras; Efstratios Karagiannidis; Marios Papadakis; George Giannakoulas
Journal:  Cardiovasc Diabetol       Date:  2022-03-14       Impact factor: 9.951

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.